The Association of Epstein-Barr Virus With Cancer

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2022 Aug 1

PMID 35911302

Authors

Pragnesh D Patel

Rahmah Alghareeb

Afshan Hussain

Marvi V Maheshwari

Nabeeha Khalid

Affiliations

Soon will be listed here.

Abstract

Epstein-Barr virus (EBV) is classified as a herpesvirus and is known for being one of the few viruses that can lead to the development of cancer. This study has gathered several studies to provide evidence as to this association as well as some of the mechanisms specific to EBV that allow this to happen. The development of EBV into cancer as well as the proteins involved in this oncogenesis play a crucial role in understanding this problem as well as creating a solution for mitigating this disease process in the future. This study summarized three of the most common malignancies caused by EBV in order to consolidate information about each of them. Additional emphasis was placed on finding which EBV serum markers were seen to be most indicative of prognosis and likelihood of developing malignancy. Higher serum EBV viral DNA loads were seen to be a useful indicator in assessing the risk of various cancers and should be studied further in relation to cancers that were not mentioned in this review.

Citing Articles

The 'Oma's of the Gammas-Cancerogenesis by γ-Herpesviruses.

Banerjee A, Dass D, Mukherjee S, Kaul M, Harshithkumar R, Bagchi P Viruses. 2025; 16(12.

PMID: 39772235 PMC: 11680331. DOI: 10.3390/v16121928.

In Silico Modeling and Characterization of Epstein-Barr Virus Latent Membrane Protein 1 Protein.

Salam D, Gunasinghe K, Hwang S, Ginjom I, Chee Wezen X, Rahman T ACS Omega. 2024; 9(50):49422-49431.

PMID: 39713625 PMC: 11656244. DOI: 10.1021/acsomega.4c06868.

Bladder Adenocarcinoma in a Constellation of Multiple Site Malignancies: An Unusual Case and Systematic Review.

Porav-Hodade D, Gherasim R, Loghin A, Lazar B, Cotoi O, Badea M Diagnostics (Basel). 2024; 14(22).

PMID: 39594177 PMC: 11592427. DOI: 10.3390/diagnostics14222510.

Performance evaluation of the high-throughput quantitative Alinity m Epstein-Barr virus assay.

Goldstein D, Sasaki M, Narlieva M, Nhan N, Liu T, Kegl A Microbiol Spectr. 2024; 13(1):e0150724.

PMID: 39545735 PMC: 11705799. DOI: 10.1128/spectrum.01507-24.

Advancements in LAMP-Based Diagnostics: Emerging Techniques and Applications in Viral Detection with a Focus on Herpesviruses in Transplant Patient Management.

Gomes Torres A, Mathias C, Baal S, Kohler A, Cunha M, Blanes L Int J Mol Sci. 2024; 25(21).

PMID: 39519059 PMC: 11546353. DOI: 10.3390/ijms252111506.

References

Green M, Rodig S, Juszczynski P, Ouyang J, Sinha P, ODonnell E . Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy. Clin Cancer Res. 2012; 18(6):1611-8. PMC: 3321508. DOI: 10.1158/1078-0432.CCR-11-1942. View

Mancao C, Altmann M, Jungnickel B, Hammerschmidt W . Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus. Blood. 2005; 106(13):4339-44. PMC: 1895254. DOI: 10.1182/blood-2005-06-2341. View

Womack J, Jimenez M . Common questions about infectious mononucleosis. Am Fam Physician. 2015; 91(6):372-6. View

Kennedy G, Komano J, Sugden B . Epstein-Barr virus provides a survival factor to Burkitt's lymphomas. Proc Natl Acad Sci U S A. 2003; 100(24):14269-74. PMC: 283581. DOI: 10.1073/pnas.2336099100. View

Huang S, Wu C, Cheng Y, Chou S, Jiang Y, Chu K . Epstein-Barr virus BRLF1 induces genomic instability and progressive malignancy in nasopharyngeal carcinoma cells. Oncotarget. 2017; 8(45):78948-78964. PMC: 5668011. DOI: 10.18632/oncotarget.20695. View

Ebell M . Epstein-Barr virus infectious mononucleosis. Am Fam Physician. 2004; 70(7):1279-87. View

Bargou R, Emmerich F, Krappmann D, Bommert K, Mapara M, Arnold W . Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest. 1998; 100(12):2961-9. PMC: 508507. DOI: 10.1172/JCI119849. View

Kaymaz Y, Oduor C, Aydemir O, Luftig M, Otieno J, Ongecha J . Epstein-Barr Virus Genomes Reveal Population Structure and Type 1 Association with Endemic Burkitt Lymphoma. J Virol. 2020; 94(17). PMC: 7431785. DOI: 10.1128/JVI.02007-19. View

Gruhne B, Sompallae R, Marescotti D, Kamranvar S, Gastaldello S, Masucci M . The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. Proc Natl Acad Sci U S A. 2009; 106(7):2313-8. PMC: 2650153. DOI: 10.1073/pnas.0810619106. View

10.

Allday M . How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?. Semin Cancer Biol. 2009; 19(6):366-76. PMC: 3770905. DOI: 10.1016/j.semcancer.2009.07.007. View

11.

Odumade O, Hogquist K, Balfour Jr H . Progress and problems in understanding and managing primary Epstein-Barr virus infections. Clin Microbiol Rev. 2011; 24(1):193-209. PMC: 3021204. DOI: 10.1128/CMR.00044-10. View

12.

Guikema J, Schuuring E, Kluin P . Structure and consequences of IGH switch breakpoints in Burkitt lymphoma. J Natl Cancer Inst Monogr. 2008; (39):32-6. DOI: 10.1093/jncimonographs/lgn020. View

13.

Houen G, Trier N . Epstein-Barr Virus and Systemic Autoimmune Diseases. Front Immunol. 2021; 11:587380. PMC: 7817975. DOI: 10.3389/fimmu.2020.587380. View

14.

Epstein A . Burkitt lymphoma and the discovery of Epstein-Barr virus. Br J Haematol. 2012; 156(6):777-9. DOI: 10.1111/j.1365-2141.2011.09008.x. View

15.

Murray P, Young L . An etiological role for the Epstein-Barr virus in the pathogenesis of classical Hodgkin lymphoma. Blood. 2019; 134(7):591-596. DOI: 10.1182/blood.2019000568. View

16.

Wang C, Zou S, Chen D, Wang J, Zheng Y, Chen X . Latent Epstein-Barr virus infection status and prognosis in patients with newly diagnosed Hodgkin lymphoma in Southeast China: a single-center retrospective study. Hematology. 2021; 26(1):675-683. DOI: 10.1080/16078454.2021.1971864. View

17.

Hsiao F, Tai A, Deglon A, Sutkowski N, Longnecker R, Huber B . EBV LMP-2A employs a novel mechanism to transactivate the HERV-K18 superantigen through its ITAM. Virology. 2008; 385(1):261-6. DOI: 10.1016/j.virol.2008.11.025. View

18.

Carpenter L, Newton R, Casabonne D, Ziegler J, Mbulaiteye S, Mbidde E . Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda. Int J Cancer. 2007; 122(6):1319-23. DOI: 10.1002/ijc.23254. View

19.

Hashmi A, Hussain Z, Hashmi K, Zafar M, Edhi M, Faridi N . Latent membrane protein 1 (LMP1) expression in Hodgkin lymphoma and its correlation with clinical and histologic parameters. World J Surg Oncol. 2017; 15(1):89. PMC: 5397827. DOI: 10.1186/s12957-017-1147-y. View

20.

Ansell S . Hodgkin lymphoma: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol. 2016; 91(4):434-42. DOI: 10.1002/ajh.24272. View